Thursday, May 26, 2022
High Yields Cannabis/Marijuana/ Weed News
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
  • Home
  • Cannabis Stocks
  • Cannabis Strains
  • Cannabis Laws
    • Marijuana Laws in All 50 States
    • International Marijuana Laws 2021
  • Product Reviews
  • Growing
  • Write for Us
No Result
View All Result
High Yields
No Result
View All Result
Home Cannabis Stock Quotes & News

Gage Growth Q1 Revenue Increases 219% to $17.6 Million

Jeremy Vedder by Jeremy Vedder
March 10, 2022
in Cannabis Stock Quotes & News, Gage Growth
0
Gage Growth Q1 Revenue Increases 219% to $17.6 Million

READ ALSO

Rubicon Organics Amends and Grants Stock Options

Resonate Blends Partners with California’s Top Licensed

Look, I know what you’re going to say: “This is marijuana and you’re writing about a cannabis company,” and you’re right, it’s marijuana but anyone who knows anything about the industry knows that cannabis companies are about as common as unicorns these days. But here’s the thing, at this time last year Gage Growth was a $1.1 million company with $4.6 million in revenues. This year, it made $17.6 million. That’s 219 percent growth. Now, keep in mind that this is a Canadian company that operates in Canada so I don’t know if we can really call these numbers “growth”. Regardless, when you look at the company’s revenue growth, it seems like the model is

The company reported Q1 revenue of $17.6 million, up from $5.8 million in Q1 2017. “This growth is attributable to our strong position in the cannabis and hemp markets, as well as an increased focus on the international markets such as Canada, Australia, and Germany,” comments Gage Chief Executive Officer, Stephen Shearin. “Gage has also announced several key additions to our management team, including the appointment of David Moen, as the new Chief Financial Officer.”

Gage Growth Q1 Revenue Increases 219% to $17.6 Million

Gage Growth Corp. announces record results for the first quarter of 2021 and provides an update on thebusiness
  • Record revenues for the first quarter of 2021 were $17.6 million, up 219.4% year over year and 67.9% quarter over quarter.
  • At the end of the quarter, cash and cash equivalents exceeded $43.6 million.
  • Gross margin was 26.1%, up from 17.3% in the fourth quarter of 2020, up 880 basis points in the quarter.
  • In April, total cannabis sales in Michigan reached $154 million, or about $1.85 billion on an annual basis. That makes Michigan the third-largest cannabis market in the United States, according to the study.
  • Eight active acres (three managed by Gage and five contracted), up from two acres in the first quarter of 2020; the company expects to increase the number of acres to 13 by the end of the year.
  • A high average basket – $158 in Q1 2021.
  • The company’s own processing plant is expected to be commissioned in the third quarter of 2021, further increasing margins.
  • A strategic agreement has been made to supply up to 10,000 pounds of Gage and Cookies premium outdoor flower varieties.

DETROIT, 27. May 2021. /PRNewswire/ – Gage Growth Corp. (Gage or the Company) (CSE: GAGE), Michigan’s leading premium cannabis brand and company, today announced its financial results for the quarter ended December 31. March 2021 announced. All currencies in this press release are expressed in US dollars unless otherwise stated. Financial highlights for the quarter ended December 31, March 2021 Gage Growth Q1 Revenue Increases 219% to $17.6 Million For more information on Gage’s use of non-IFRS financial measures and for additional reconciliations, see the non-IFRS financial measures section below. In the first quarter of 2021, revenues increased to $17.6 million from $10.5 million in the fourth quarter of 2020, an increase of 67.9%. This significant increase over the previous quarter is mainly due to the expansion of cultivation capacity and the opening of two new clinics. Gross margin before fair value gains on biological assets was 26.1% in the first quarter of 2021, compared to 17.3% in the fourth quarter of 2020. Gross margin increased 880 basis points from the previous quarter to 26.1%, driven by higher retail margin and increased cultivation capacity through acreage managed by Gage, contract growers and lower production costs through committed wholesale partners. The company expects margins to continue to increase in the second quarter of 2021 compared to the prior quarter, driven by higher returns on Gage-managed assets and new contract growth partners. Remark of the management Following Gage’s tremendous growth this quarter, with revenue of $17.6 million, we expect revenue in the first half of 2021 to surpass that of the full year 2020 and more than double that of the first half of 2020.

Fabian Monaco, Director of Gage

Gage Growth Q1 Revenue Increases 219% to $17.6 Million We are growing rapidly as our investments in infrastructure begin to deliver operational value and the team continues to respond to the changing needs of our patients, clients and communities. Mr. Monaco continued: Demand for Gage’s products and shopping experience, as well as the Michigan market, is extremely high as cannabis continues to do well as a mainstream product. During the quarter, we opened two new pharmacies, including the first Cookies branded adult pharmacy in the Midwest. We opened our Battle Creek store in late April, bringing our total number of outlets to eight. In terms of agriculture, the company’s three farms are fully operational and meeting growing consumer demand, while we continue to optimize yields and efficiency. All this is made possible by the dedicated staff of our organization. Mr. Monaco concluded: Overall, we will continue to execute our growth strategy in 2021. We look forward to building on this momentum and are already seeing great results as we continue to expand our store network and increase square footage. Operational updates and developments

  1. External diversion agreement
    • The Company is pleased to announce that it has entered into an agreement to supply up to £10,000 per annum of premium floral varieties of Gage and Cookies.
    • This underscores the company’s continued commitment to expanding its product line and brand with a low capital expenditure strategy, with an attractive cost per pound of just $400, which will further increase margins.
    • Will expand the Company’s color offering and provide cost-effective supplies for recycling initiatives in H2 2021 and H1 2022.
  2. Opening of the 9th pharmacy led by Gage on the 28th. May 2021 in Jackson, Michigan
    • The company is continuing its retail expansion strategy, aiming to open 20 stores by the end of the year.
  3. Enable more cultivation and open a processing lab to meet consumer demand.
    • The Company’s portfolio currently includes eight cultivation operations (three Gage-managed and five contract cultivation operations), while only two operations were active in the first quarter of 2020.
    • The expansion of the Monitor’s Phase II seed is expected to be completed in the fourth quarter. The project will be completed in the second quarter of 2021. The 80,000 square foot building is already complete and interior work will begin at the end of the second quarter.
    • Five contract growers are currently active, three of whom are already delivering and the other two are in the process of harvesting. The company plans to add more partners by the end of the year and increase its total production capacity to more than 7,000 pounds per month by the end of the year.
    • Gage is expected to open the processing plant in the third quarter of 2021. This will enable the company to manufacture its own extract products at significantly higher margins. Additionally, the processing facility will allow the company to introduce new products (Blue River™ Extracts & Terpenes) and launch world-class brands (SLANG Worldwide).

Outlook for the 2nd quarter of 2021(1) The company confirmed its revenue forecast for the second quarter. quarter 2021 in the range of $26 million to $31 million. The company reaffirmed its guidance for higher gross profit in the second quarter of 2021 and expects a further significant increase in gross profit in the second quarter of 2021 as a result of improved productivity in its growth business and improved manufacturing costs. Notes:

  1. These preliminary and unaudited financial results are subject to the Company’s normal financial reporting procedures. Actual results may be affected by subsequent events or determinations. While the Company believes that these preliminary financial results are reasonable, they are subject to known and unknown risks and uncertainties that could cause actual results to differ materially. These preliminary financial results are forward-looking information. See the Cautionary Statement Regarding Forward-Looking Information and Statements and Financial Prospects.

Conference call The company will host a conference call on Friday, May 28, 2021 at 8:30 a.m. AND to discuss its operational and financial results and provide updates on current business developments. To join the call, dial 1-877-317-6789 for a toll-free call from the U.S. or Canada, or 1-412-317-6789 if calling from outside those countries. A recording of the conference call will be available until Friday 11. June 2021, available. To register by phone, call toll-free 1-877-344-7529 from the United States, 1-855-669-9658 from Canada, or 1-412-317-0088 if calling from outside these countries, and use the following registration PIN: 10157206. Call the conference phone number 5-10 minutes before the start time. A live audio webcast of the conference call will also be available at https://services.choruscall.com/mediaframe/webcast.html?webcastid=w3Qc6mqM. About Gage Growth Corp. Gage Growth Corp. innovates and creates the highest quality cannabis products for Michigan cannabis consumers, bringing world-class brands to market. With years of progressive industry experience, the company’s founders have successfully built and expanded businesses with federal and state licenses, including cultivation, processing and retail. Gage’s portfolio includes 19 city and state approved Class C cultivation permits, three reprocessing permits and 13 supply centers (dispensaries). More information about Gage Growth Corp. can be found at www.gagecannabis.com. Instagram: @gagecannabis Facebook: @gageusa Twitter: @gagecannabisco Sources: Gage Growth Corp. and the Marijuana Regulatory Authority. Explanation of the company’s activities References in this press release to the Company, its operations and assets include the operations and assets of certain licensed cannabis operators operating under the Gage brand pursuant to contractual agreements with the Company. For further information, please refer to the Company’s long form prospectus dated March 26, 2021 and other disclosure documents available on the Company’s website at www.sedar.com. Non-IFRS financial ratios The company presented certain financial measures not covered by IFRS, including gross margin and adjusted EBITDA. These non-IFRS measures do not have standard IFRS definitions, are not calculated and presented in accordance with IFRS, and may not be comparable to similar measures reported by other entities. The Company defines gross margin as gross profit before fair value of inventory and biological assets divided by sales. The Company calculates adjusted EBITDA as net income adjusted for the effects of the following items: Fair value adjustment on sale of inventory, fair value adjustment on growth of biological assets, provision for income taxes, foreign exchange gain (loss), change in fair value of investments, interest expense, share-based compensation, depreciation and amortization, listing fees, impairment loss, loss on financial assets. The Company has presented these non-IFRS measures as supplementary information and in addition to the financial measures calculated and presented under IFRS. The Company believes that these additional non-IFRS measures provide a valuable additional measure that can be used to assess the Company’s operating performance. Since other entities may calculate these non-IFRS measures differently than the Company, these measures may not be comparable to those of other entities. These additional non-IFRS financial measures should not be considered superior, substitute or alternative financial measures and should be considered only in conjunction with the IFRS financial measures presented herein. For a detailed reconciliation of adjusted EBITDA to net income/(loss), please refer to the Company’s Management Discussion and Analysis for the three months ended December 31. March 2021 (Management Report for the first quarter of 2021). The Company’s financial statements for the three months ended March 31, 2021 and Management’s Discussion and Analysis for the first quarter of 2021 are available on SEDAR at www.sedar.com. Warning about the cannabis trade in the United States Investors should keep in mind that the cannabis industry is subject to significant legal restrictions and regulations in the United States. Although cannabis is legal in some states, it remains a Schedule I drug under the United States Controlled Substances Act, which, among other things, makes the cultivation, distribution, and possession of cannabis illegal under United States federal law. Financial transactions involving products derived from or intended to facilitate commercial cannabis activities in the United States are subject to criminal prosecution under applicable United States federal money laundering laws. Investors should review the risk factors and information contained in the Company’s full prospectus dated March 26, 2021 and other disclosure documents available on the Company’s website at www.sedar.com. Financial perspectives This press release contains financial information as required by applicable Canadian securities laws. The financial outlook has been prepared by the Company’s management to provide guidance for the second quarter of 2021 and may not be appropriate for other purposes. The financial projections have been prepared based on a number of assumptions, including those discussed in this press release and assumptions regarding market conditions, pricing and demand. The Company’s actual results for any period are likely to differ from the amounts indicated in these forecasts, and such differences could be material. The Company and its management believe that the financial projections have been prepared on a reasonable basis. However, because this information is highly subjective and subject to numerous risks, including those described in the Cautionary Statement on Forward-Looking Information and Statements, it should not necessarily be construed as an indication of future results. Information from third parties This press release contains market and industry data derived from third-party sources, including trade publications. The Company believes that industry data is accurate and that its estimates and assumptions are reasonable, but no assurance can be given as to the accuracy or completeness of such data. Third party sources generally state that the information they contain is from sources believed to be reliable, but no guarantee is given as to the accuracy or completeness of the information they contain. Although the data is considered reliable, the Company has not independently verified the data from the third-party sources referred to in this press release and has not tested the economic assumptions underlying these sources. Original press release Stay ahead of the crowd by subscribing to 420 Investor, the largest and most comprehensive subscription service for cannabis dealers and investors since 2013. Gage Growth Q1 Revenue Increases 219% to $17.6 MillionGage Growth Q1 Revenue Increases 219% to $17.6 Million New Cannabis Ventures is committed to gathering quality content and information about leading cannabis companies to help our readers filter through the noise and stay informed about the most important news in the field. Do you have sensitive information? Please contact us.

 

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0

Related Posts

Eaze launches first dispensaries in San Diego and Santa Ana
Cannabis Stock Quotes & News

Rubicon Organics Amends and Grants Stock Options

May 26, 2022
OG Kush: The Legendary Cannabis Strain Of All Time Reviews
Cannabis Stock Quotes & News

Resonate Blends Partners with California’s Top Licensed

May 26, 2022
Pharmagreen Taps Revenue Potential of Proprietary
Cannabis Stock Quotes & News

Lifeist Announces Sale of Non-core Swedish Subsidiary

May 26, 2022
Victory Square Technologies Provides Corporate Update –
Cannabis Stock Quotes & News

Ayr Wellness Reports First Quarter 2022 Results

May 26, 2022
Allied Corp. Initiates Additional Shipment of 200kgs of CBD
Cannabis Stock Quotes & News

Akerna Announces Results of Annual Meeting of Stockholders

May 25, 2022
OG Kush: The Legendary Cannabis Strain Of All Time Reviews
Cannabis Stock Quotes & News

Verano Celebrates Opening of Largest Zen Leaf Dispensary in

May 25, 2022
Next Post
Jushi Q1 Revenue Increases 29% to $41.7 Million

Jushi Q1 Revenue Increases 29% to $41.7 Million

  • Trending
  • Comments
  • Latest
Monthly Spotlight: The Best of Plain Jane CBD

Monthly Spotlight: The Best of Plain Jane CBD

April 8, 2022
The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

The Ultimate Dr. Dabber Stella Vaporizer Review for 2022

April 19, 2022
volcano hybrid review 2022

The 2022 Volcano Hybrid Vaporizer Review: All You Need To Know

May 23, 2022
The Utillian 5 v3 Wax Pen Review for 2022

The Utillian 5 v3 Wax Pen Review for 2022

March 27, 2022

The 7 Best Smell-Proof Weed Bags To Keep Your Bud Stash Safe

April 27, 2022
The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

The Best Synthetic Urine Kit to Pass Your Drug Test in 2022

May 23, 2022
The 10 Best Smell Proof Backpacks for Weed in 2022

The 10 Best Smell Proof Backpacks for Weed in 2022

May 5, 2022
Eaze launches first dispensaries in San Diego and Santa Ana

Rubicon Organics Amends and Grants Stock Options

May 26, 2022
Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

Former NFL Running Back Marshawn Lynch Launches Premium Blunt Brand

0
Major Marijuana Coalition Forms To Coordinate Legalization Push, But Some Key Advocacy Players Aren’t Involved

Major Marijuana Coalition Forms To Coordinate Legalization Push

0
MMJRecs - cannabis leaf

How Medical Marijuana Can Help Treat Sleep Disorders

0
Colorado Cannabis Sales Exceed $2 Billion in 2020

Colorado Cannabis Sales Exceed $2 Billion in 2020

0
Eaze launches first dispensaries in San Diego and Santa Ana

Rubicon Organics Amends and Grants Stock Options

May 26, 2022
California state agency weighs changes to pre-employment drug test appeal policy

Body and Mind Provides Update on ShowGrow Dispensaries in California

May 26, 2022
OG Kush: The Legendary Cannabis Strain Of All Time Reviews

Resonate Blends Partners with California’s Top Licensed

May 26, 2022
Pharmagreen Taps Revenue Potential of Proprietary

Lifeist Announces Sale of Non-core Swedish Subsidiary

May 26, 2022

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • March 2020

Categories

  • 1933 Industries
  • 4front Ventures
  • Acreage Holdings
  • Ascend Wellness
  • Ayr Wellness
  • Body & Mind
  • C21 Investments
  • Cannabis Stock Quotes & News
  • Cansortium Inc
  • Captor Capital
  • Ceres Acquisition Corp
  • Chalice Brands
  • Columbia Care
  • Cresco Labs
  • CuraLeaf
  • Gage Growth
  • Glass House Brands
  • Green Thumb Industries
  • Grown Rogue International
  • Harborside
  • Item 9 Labs
  • Jushi Holdings
  • Lowell Farms
  • MariMed
  • MedMen Enterprises
  • News
  • Next Green Wave
  • Planet 13
  • Plus Products
  • Product Reviews
  • Red White & Bloom
  • SLANG Worldwide
  • Sol Global Investments
  • TerrAscend
  • TILT Holdings
  • Trulieve
  • Verano Holdings
  • Vext Sciences
  • Vibe Growth

Recent Posts

  • Rubicon Organics Amends and Grants Stock Options
  • Body and Mind Provides Update on ShowGrow Dispensaries in California
  • Resonate Blends Partners with California’s Top Licensed
  • Lifeist Announces Sale of Non-core Swedish Subsidiary

QR Code

Gage Growth Q1 Revenue Increases 219% to $17.6 Million
No Result
View All Result
  • Homepages
    • Home Page 1
  • News

© 2021 High Yields